Replies to post #20126 on Ayala Pharmaceuticals Inc (ADXS)

[shub]

Husker: Neo is still preclinical and preclinical drug candidates have huge odds agains success and many years of trials before the FDA even considers them for approval. Further, we are not the only ones working on the concept.
Neo is not where the value lies here, i think.

[ignatiusrielly35]

Even if NEO works better than the base vaccines, not everyone, and not every country, will go for it. It will be more expensive for customized treatment. There should be room for both. And NEO has not even begun a trial yet. Even assuming NEO gets accelerated approval, that is still many years away. My bet has always been that Amgen will buy the whole company, and have the unlicensed base vaccines for now, eventually culminating in the coup de grace, the approval of NEO as the closest thing to a cure for cancer.

[shortridge3w]

NEO vs Axalimogene filolisbac just like Honda crv vs Porsche. Majority of people will buy Honda crv while Porsche is only for specific customers.